Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis. uri icon

Overview

abstract

  • BACKGROUND: Persistent hyperinsulinemic hypoglycemia of infancy (PHHI), also known as congenital hyperinsulinism, has been known to go into spontaneous remission, with patients developing diabetes in later life. A temporary phase of hyperglycemia is, however, rarely reported. CASE PRESENTATION: We describe a 16-month-old child, a known case of diazoxide responsive PHHI, presenting with mixed hyperglycemic hyperosmolar coma and ketoacidosis with rhabdomyolysis while on diazoxide treatment. The patient required temporary cessation of diazoxide and initiation of insulin infusion, followed by a relapse of hypoglycemia again necessitating diazoxide therapy. CONCLUSIONS: Hyperosmolar coma with ketoacidosis is a rare side-effect of diazoxide therapy, documented even in patients with persistent hyperinsulinemic hypoglycemia of infancy.

publication date

  • August 28, 2018

Research

keywords

  • Antihypertensive Agents
  • Congenital Hyperinsulinism
  • Diazoxide
  • Hyperglycemic Hyperosmolar Nonketotic Coma
  • Ketosis

Identity

Scopus Document Identifier

  • 85049507968

Digital Object Identifier (DOI)

  • 10.1515/jpem-2018-0112

PubMed ID

  • 29958183

Additional Document Info

volume

  • 31

issue

  • 8